The first study, by Yancopoulos and colleagues, investigated this issue using VEGF Trap (aflibercept), a fully human soluble receptor protein with VEGF receptor 1 (VEGFR1) and VEGFR2 domains ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback